The DOTA-KS83 minibody was radiolabeled with 64Cu, and tumor targeting was evaluated in mice bearing HEC1A/EMP2, HEC1A, and Ramos (EMP2-negative) xenografts. This evidence concerns the gene EMP2 and neoplasm.